Common Stock
Dicerna Pharmaceuticals Inc
NASDAQ:DRNA (12/27/2021, 7:42:47 PM)
After market: 38.24 +0.02 (+0.05%)38.22
+0.22 (+0.58%)
Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The company is headquartered in Lexington, Massachusetts and currently employs 302 full-time employees. The company went IPO on 2014-01-30. The firm is focused on discovering, developing, and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to silence selectively genes that cause or contribute to disease. The firm's GalXC RNAi technology Platform consists of its liver-targeted GalXC technology and GalXC-Plus technology for tissues outside the liver. The firm's product line includes nedosiran, RG6346, belcesiran, and DCR-AUD. Its lead product candiadate nedosiran is a RNAi drug candidate developed for the treatment of hyperoxaluria (PH). The RG6346 for the treatment of chronic hepatitis B virus (HBV) infection. The belcesiran for the treatment of alpha-1 antitrypsin deficiency-associated liver disease (AATLD). The DCR-AUD for the treatment of alcohol use disorder (AUD).
Dicerna Pharmaceuticals Inc
75 Hayden Avenue
Lexington MASSACHUSETTS 02421
P: 16176218097.0
CEO: Douglas M. Fambrough
Employees: 302
Website: http://www.dicerna.com/
Eli Lilly inked a deal worth $60 million to get in on a gene-editing drug for elevated lipoprotein A.
/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Rogers Corporation (NYSE: ROG)...
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: ADTRAN, Inc. (NASDAQ: ADTN)...
Here you can normally see the latest stock twits on DRNA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: